Explore evidence

1 patientDuring 34 months of follow-up, one patient (1.6%) had third-line treatment.

Côte d'IvoireVIH/sidaobserved 34 monthspublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

465 /mm3The median pre-antiretroviral treatment CD4 count was 465 cells per cubic millimeter among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2022BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/s12879-022-07082-2

0.6 %At 10 years, scale-back strategies increase projected HIV deaths by 0.6% to 39.1%.

Côte d'IvoireVIH/sidaobserved 10 yearspublished 2017Annals of internal medicineeurope_pmcdocument of 6 observations

2.8 %Arterial thrombosis was found in 1 out of 36 HIV-infected patients, representing 2.8%.

Côte d'Ivoirearterial thrombosis · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

60 patientsOnly 60 AEB patients completed one actual month of antiretroviral treatment.

Côte d'IvoireVIH/sidaobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

6.8 per_100_person-yearsIn a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of lipodystrophy was 6.8 per 100 person-years of follow-up after 3 years of combined antiretroviral therapy.

Côte d'Ivoirelipodystrophy · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations

38 %Among 823 hospitalized HIV-positive adults in West Africa, 38% died during hospitalization.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

4.3 aORHIV infection was associated with cervical cancer (aOR 4.3 [CI 2.2-8.3]).

Côte d'Ivoirecancer du col de l'utérus · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations

5.8 yearsParticipants in the Temprano ANRS 12136 posttrial phase had a median follow-up duration of 5.8 years.

Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations

7.9 odds_ratioCervical cancer was associated with HIV infection with an odds ratio of 7.9.

Côte d'Ivoirecancer du col de l'utérus · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

73,525 individualsThe study included 73,525 ART-naïve PLHIV-1 adults aged >16 years initiating ART.

Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations

70.2 %Most of the treatment-naïve patients (70.2%) had CD4-T cell count ≥500 cells/mm3.

Côte d'IvoireVIH/sidaobserved 2012published 2015PloS oneeurope_pmcdocument of 9 observations

12.9 per_100_person_yearsThe incidence rate of bacterial infections was 12.9 per 100 person-years among HIV-HBV co-infected patients with HBV-replication > 10,000 copies/mL.

Côte d'Ivoirehépatite B · VIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016

32 %Among hospitalized HIV-positive adults in West Africa, other infections were the underlying cause of hospitalization in 32% of patients.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

11.2 %Among the 1644 cancer patients enrolled, 184 (11.2%) were identified as HIV-infected.

Côte d'Ivoirecancer (non précisé) · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations

456 cells/mm3The median baseline CD4 count was 456 cells/mm³.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

18.1 %In a cohort of HIV-infected patients of sub-Saharan African origin, the cumulative incidence of lipodystrophy was 18.1% after 3 years of combined antiretroviral therapy.

Côte d'Ivoirelipodystrophy · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations

24 %Among HIV-infected adults interviewed, 24% could be recommended not to start antiretroviral treatment (ART) because their partner was seropositive.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations

4.3 %HIV incidence among female sex workers whose usual price was less than 3.50$ in Côte d'Ivoire was 4.3%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988

80.5 %80.5% of patients completed 28 days of antiretroviral chemoprophylaxis.

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations

70.2 %Among 791 HIV-infected patients, 555 (70.2%) were on antiretroviral therapy.

Côte d'IvoireVIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

20.8 hoursThe average delay before consultation after HIV exposure was 20.8 hours.

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations

43 patientsAmong 43 HBeAg-negative HIV/HBV co-infected patients not indicated for ART in Côte d'Ivoire, 17 (40%) consistently had 'infection', 5 (12%) consistently had 'hepatitis', and 21 (48%) fluctuated between phases during follow-up.

Côte d'Ivoirehépatite B · VIH/sidapublished 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations

5.8 yearsParticipants were followed for a median of 5.8 years.

Côte d'IvoireVIH/sidapublished 2022HIV medicineeurope_pmcdocument of 6 observations

10.5 %Among the 95 HIV-2 patients enrolled in the 'success cohort', 10 (10.5%) were reported dead.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations